TrivarX Limited
MDBIF
$0.0244
$0.02231,061.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 48,114.29% | 49,471.43% | -- | -- | -90.28% |
| Total Other Revenue | 388.71% | 395.24% | -- | -- | -97.99% |
| Total Revenue | 5,154.29% | 5,301.43% | 286,500.00% | 285,900.00% | -97.78% |
| Cost of Revenue | 480.00% | 500.00% | -- | -- | 900.00% |
| Gross Profit | 5,931.67% | 6,103.33% | 286,500.00% | 285,900.00% | -98.10% |
| SG&A Expenses | 55.46% | 59.16% | 35.24% | 31.94% | 7.68% |
| Depreciation & Amortization | -30.92% | -29.41% | -83.32% | -83.80% | -82.67% |
| Other Operating Expenses | -13.34% | -11.30% | 11.29% | 8.51% | 21.52% |
| Total Operating Expenses | 9.24% | 11.79% | -9.31% | -11.56% | -20.98% |
| Operating Income | 93.90% | 93.76% | 73.88% | 74.52% | -158.48% |
| Income Before Tax | 91.60% | 91.42% | 87.01% | 87.32% | -155.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 91.60% | 91.42% | 87.01% | 87.32% | -155.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 91.60% | 91.42% | 87.01% | 87.32% | -155.75% |
| EBIT | 93.90% | 93.76% | 73.88% | 74.52% | -158.48% |
| EBITDA | 96.77% | 96.69% | 63.81% | 64.70% | -604.64% |
| EPS Basic | 91.67% | 91.67% | 93.33% | 93.48% | -33.33% |
| Normalized Basic EPS | 100.00% | 100.00% | 85.71% | 85.71% | -40.00% |
| EPS Diluted | 91.67% | 91.67% | 93.33% | 93.48% | -33.33% |
| Normalized Diluted EPS | 100.00% | 100.00% | 85.71% | 85.71% | -40.00% |
| Average Basic Shares Outstanding | 48.47% | 48.47% | 81.40% | 81.40% | 94.30% |
| Average Diluted Shares Outstanding | 48.47% | 48.47% | 81.40% | 81.40% | 94.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |